Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Incannex

Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders

Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several U.S.

Unrivaled Brands & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About

Unrivaled Brands & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug

Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the Bellberry Human Research Ethics Committee ('HREC') for a phase 1 clinical trial investigating its proprietary multi-use, anti-inflammatory drug IHL-675A

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, has completed an analysis of data from the Phase 2 proof-of-concept clinical trial invest

Incannex Healthcare To Acquire APIRx Pharmaceuticals For $93.3M

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL) announced that it has executed a term sheet with binding commercial terms to wholly acquire APIRx Pharmaceutical USA, LLC, subject to shareholder approval under ASX listing Rule 7.1.

What's Going On With Incannex Healthcare's Stock Today?

Incannex Healthcare Ltd (NASDAQ: IXHL) is soaring Tuesday on abnormally-high volume.

Incannex's Cannabinoid Combo Product Reduces AHI In Sleep Apnea Patients

Incannex Healthcare Limited (NASDAQ: IXHL) has

inkl

Read news from The Economist, FT, and more,
with one subscription

Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results

Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received full approval in both Utah chambers, standing out from among dozens of measures currently circulating in legislatures across several U.S. states. Psychedelic science also took an important step forward with the publication…

Psychedelics And Virtual Reality Treatment Developed By Monash University, Funded By Incannex

Psychedelics And Virtual Reality Treatment Developed By Monash University, Funded By Incannex

Incannex Healthcare Limited (NASDAQ:IXHL) (ASX:IHL) has implemented a license agreement with Monash University to develop a novel treatment that combines virtual reality and psychedelics. This marks the initiation of a second clinical psychedelic therapy program. "We're delighted to have commenced this exciting project and to have expanded our partnership with…

Medicinal Cannabis And Psychedelics Company Incannex Lists American Depositary Shares On Nasdaq

Medicinal Cannabis And Psychedelics Company Incannex Lists American Depositary Shares On Nasdaq

Medicinal cannabis and psychedelics company Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) commenced trading of its American Depositary Shares representing its ordinary shares on the Nasdaq Global Market under the ticker symbol 'IXHL'.

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Monash University

Johns Hopkins University

Field Trip Health

Benzinga Cannabis Capital Conference

American Depositary Shares

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Eating Disorders

Places

231,455 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play